search
Back to results

Safety and Efficacy of Percutaneous Carpal Tunnel Release Versus Open Surgery (CATS)

Primary Purpose

Carpal Tunnel Syndrome

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Open surgery
Percutaneous surgery
Sponsored by
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Carpal Tunnel Syndrome focused on measuring Percutaneous carpal tunnel release

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Over 18 years old.
  • Positive electromyography, confirming carpal tunnel syndrome.
  • Capable to understand risks and advantages of both procedures.
  • Normal blood tests.

Exclusion Criteria:

  • Previous carpal tunnel release in the same hand.
  • Previous fracture or dislocation in the area around the forearm, wrist or hand.
  • Signs or symptoms of infection.
  • Psychiatric disorders.
  • Antiplatelet or anticoagulant therapy, that cannot be suspended due to underlying pathology, and does not allow the surgery to be performed.
  • Coagulation disorders, or any underlying pathology, with high risk of thrombosis or bleeding.

Sites / Locations

  • Hospital Arnau de Vilanova/Lliria

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Open surgery

Percutaneous surgery

Arm Description

30 patients will be operated with an open carpal tunnel release.

30 patients will be operated with a percutaneous carpal tunnel release.

Outcomes

Primary Outcome Measures

Change in Boston Carpal Tunnel Questionnaire
Outcomes from both interventions will be measured with this symptom severity and functional status carpal tunnel specific scale. The range of the final results are from 19 (no symptoms) to 95 (severe symptoms).

Secondary Outcome Measures

Visual Numeric Scale
Pain relief will be measured with the VNS. The range of the scale is from 0 (no symptoms) to 10 (severe symptoms).
Quick-DASH (Disabilities of Arm, Shoulder and Hand)
Disabilities of the hand will be measured with Quick-DASH. The range of the final results are from 0 (no symptoms) to 100 (severe symptoms).
Douleur Neuropathique 4 questions (DN4)
Neuropathic pain relief with the DN4. The range of the final results are from 0 (no symptoms) to 10 (severe symptoms). A result of more than 4 indicates neuropathic pain.
Consumer Reports Effectiveness Scale (CRES-4)
Patient´s satisfaction after the procedures The range of the final results are from 0 to 300. A higher score indicates a better outcome of the treatment for the patient.
Time off work
Differences in time off work between both procedures measured in days.
Grip strength
Measured in Kilograms with a "Deyard EH101" dynamometer
Number of other complications
Any complication will be recorded.

Full Information

First Posted
August 11, 2019
Last Updated
March 21, 2022
Sponsor
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
search

1. Study Identification

Unique Protocol Identification Number
NCT04117516
Brief Title
Safety and Efficacy of Percutaneous Carpal Tunnel Release Versus Open Surgery
Acronym
CATS
Official Title
Safety and Efficacy of Percutaneous Carpal Tunnel Release Versus Open Surgery: a Randomized Clinical Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Completed
Study Start Date
June 5, 2019 (Actual)
Primary Completion Date
November 30, 2021 (Actual)
Study Completion Date
November 30, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Hypothesis: Percutaneous ambulatory carpal tunnel release offers similar outcomes to the open approach in the theatre. Study design: Two-groups randomized single-blind interventional non-inferiority clinical trial.
Detailed Description
Background: Carpal tunnel syndrome (CTS) is the most common compressive neuropathy in the upper limb, with a prevalence of around 1'14% and 14'4% of the population. The clinical symptoms are usually pain, paresthesias and numbness on the sensitive distribution territory of the median nerve in the hand. Conservative treatment is used for the mild cases, and surgery for the moderate and severe ones, or when the conservative treatment has failed. Open carpal tunnel release is the gold standard surgery, with a short longitudinal volar approach that allows to visualize the complete division of the ligament. Over the last few years, endoscopic techniques have been introduced, offering some advantages such as: lower postoperative pain, earlier return to work and less complications due to the wound. Despite this, it has not been popularised, probably, because it is a challenging and more expensive surgical procedure. Based on the minimally invasive endoscopic approach, and with the aim of obtaining the same benefits, and avoid the complications of the open surgery, several devices have been developed to perform a percutaneous release. Hypothesis: Percutaneous ambulatory carpal tunnel release offers similar outcomes to the open approach in the theatre. Study design: Two-groups randomized single-blind interventional non-inferiority clinical trial. Methods: Sixty patients reporting CTS symptoms, that are confirmed by clinical exam and nerve conduction studies, will be included. Participants will be randomized in two arms. Patients from one group will be operated with an open carpal tunnel release, in the theatre, with tourniquet, under local anesthesia and sedation, through a short longitudinal volar "classical" approach of the hand, that allows to visualize the complete division of the ligament. The other group will be operated with a percutaneous approach, ambulatory, with a short transverse volar approach, 1-2cm proximal to the wrist, under Wide Awake Local Anesthesia with No Tourniquet. The main outcome measures will be the Boston Carpal Tunnel Questionnaire, Quick DASH questionnaire, Douleur Neuropathique 4 questions, Visual Numeric Scale and grip strength. The scales and questionnaires will be administrated to participants preoperative, 4 weeks and 24 weeks postoperative.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Carpal Tunnel Syndrome
Keywords
Percutaneous carpal tunnel release

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Open surgery
Arm Type
Active Comparator
Arm Description
30 patients will be operated with an open carpal tunnel release.
Arm Title
Percutaneous surgery
Arm Type
Experimental
Arm Description
30 patients will be operated with a percutaneous carpal tunnel release.
Intervention Type
Procedure
Intervention Name(s)
Open surgery
Intervention Description
Open carpal tunnel release will be performed, in the theatre, with tourniquet, under local anesthesia and sedation, through a short longitudinal volar "classical" approach of the hand, that allows to visualize the complete division of the ligament.
Intervention Type
Procedure
Intervention Name(s)
Percutaneous surgery
Intervention Description
Percutaneous carpal tunnel release will be performed, ambulatory, with a percutaneous scalpel, through a short transverse volar approach, 1-2cm proximal to the wrist, under Wide Awake Local Anesthesia with No Tourniquet.
Primary Outcome Measure Information:
Title
Change in Boston Carpal Tunnel Questionnaire
Description
Outcomes from both interventions will be measured with this symptom severity and functional status carpal tunnel specific scale. The range of the final results are from 19 (no symptoms) to 95 (severe symptoms).
Time Frame
Preoperative, 4 weeks and 24 weeks after surgery.
Secondary Outcome Measure Information:
Title
Visual Numeric Scale
Description
Pain relief will be measured with the VNS. The range of the scale is from 0 (no symptoms) to 10 (severe symptoms).
Time Frame
Preoperative, 4 weeks and 24 weeks after surgery.
Title
Quick-DASH (Disabilities of Arm, Shoulder and Hand)
Description
Disabilities of the hand will be measured with Quick-DASH. The range of the final results are from 0 (no symptoms) to 100 (severe symptoms).
Time Frame
Preoperative, 4 weeks and 24 weeks after surgery.
Title
Douleur Neuropathique 4 questions (DN4)
Description
Neuropathic pain relief with the DN4. The range of the final results are from 0 (no symptoms) to 10 (severe symptoms). A result of more than 4 indicates neuropathic pain.
Time Frame
Preoperative, 4 weeks and 24 weeks after surgery.
Title
Consumer Reports Effectiveness Scale (CRES-4)
Description
Patient´s satisfaction after the procedures The range of the final results are from 0 to 300. A higher score indicates a better outcome of the treatment for the patient.
Time Frame
24 weeks after surgery.
Title
Time off work
Description
Differences in time off work between both procedures measured in days.
Time Frame
24 weeks after surgery.
Title
Grip strength
Description
Measured in Kilograms with a "Deyard EH101" dynamometer
Time Frame
Preoperative, 4 weeks and 24 weeks after surgery.
Title
Number of other complications
Description
Any complication will be recorded.
Time Frame
4 weeks and 24 weeks after surgery.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Over 18 years old. Positive electromyography, confirming carpal tunnel syndrome. Capable to understand risks and advantages of both procedures. Normal blood tests. Exclusion Criteria: Previous carpal tunnel release in the same hand. Previous fracture or dislocation in the area around the forearm, wrist or hand. Signs or symptoms of infection. Psychiatric disorders. Antiplatelet or anticoagulant therapy, that cannot be suspended due to underlying pathology, and does not allow the surgery to be performed. Coagulation disorders, or any underlying pathology, with high risk of thrombosis or bleeding.
Facility Information:
Facility Name
Hospital Arnau de Vilanova/Lliria
City
Valencia
ZIP/Postal Code
46015
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Safety and Efficacy of Percutaneous Carpal Tunnel Release Versus Open Surgery

We'll reach out to this number within 24 hrs